Furthermore, an ET-1 receptor antagonist was shown to improve the vascular endothelial function of a patient with coronary heart disease (CHD), confirming that ET-1 plays an important role in ED and the development of atherosclerosis in the early stage to some extent [44]. This evidence concerns the gene EDN1 and coronary artery disorder.